Units Plummets After Novo Nordisk Deal Failure
Shares of HIMS experienced a dramatic slump today following the unexpected withdrawal of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by nearly fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that